Here are three points:
1. The grants total $155,000.
2. The funds will help Bacterin International, a Xtant wholly-owned subsidiary, expand its orthobiologic process facility.
3. The grants will specifically contribute to new processing equipment, new job creation and job training.
More articles on devices:
Spinal Elements hits 50 US patents — 5 things to know
RBC Capital increases Stryker price target to $120 — 5 key facts
21 spine devices receive FDA 510(k) clearance in March
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
